Form 4 for CRVO CervoMed Inc.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001437749-25-035654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 2025-11-17 | CRVO | Gregoire Sylvie | Dir, 10% | P - Purchase | $8.46 | +10.8K | 1.48M | +0.7% | +$91.3K | |
| I | 2025-11-19 | 2025-11-17 | CRVO | Gregoire Sylvie | Dir, 10% | P - Purchase | $8.46 | +10.8K | 12.5K | +638% | +$91.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | P | A | 10,793 | $8.46 | 1,484,078 | D Spouse's IRA | — | — | (F1) Shares purchased in open-market transactions. (F2) The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.38 to $8.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range. (F3) Includes (i) 1,471,578 hares held jointly by the Reporting Person and her spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors and (ii) 12,500 shares held by the Sylvie Gregoire Roth IRA. (F4) Shares held by the John J. Alam Roth IRA. |
| 2 | Common | Common Stock | 2025-11-17 | P | A | 10,807 | $8.46 | 12,500 | I | — | — | (F4) Shares held by the John J. Alam Roth IRA. (F1) Shares purchased in open-market transactions. (F5) The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.39 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range. |